Loopback Analytics Welcomes Industry Leader Elizabeth Cherry as Vice President of Access Solutions

DALLAS, July 24, 2025 /PRNewswire/ -- Loopback Analytics is excited to welcome Elizabeth Cherry, PharmD, MMHC, CSP, as Vice President of Access Solutions. A recognized leader in specialty pharmacy and market access strategy, Cherry brings extensive expertise in building innovative partnerships between health system specialty pharmacies and life sciences manufacturers.

Cherry previously served as Senior Director of Trade Relations and Market Access at Vanderbilt Specialty Pharmacy, where she led initiatives to align manufacturers, payors, and health systems to improve access to high-cost, complex medications. Her work resulted in nationally recognized frameworks for collaborative access models that delivered measurable patient outcomes.

"Elizabeth combines strategic insight with operational depth," said Neil Smiley, CEO of Loopback. "Her leadership will be instrumental in helping Loopback strengthen its network and deliver measurable value to both our life sciences partners and the health systems we support."

At Vanderbilt, Cherry played a pivotal role in expanding access to limited distribution drugs (LDDs) by developing legal, operational, and data frameworks that enabled long-term partnerships between manufacturers and integrated delivery networks (IDNs). Her work focused on aligning manufacturer goals with health system infrastructure to drive real-world impact.

A Certified Specialty Pharmacist and frequent speaker at Asembia, NASP, and the IDN & Bio/Pharma Partnering Summit, Cherry is widely respected for her thought leadership on breaking down silos between life sciences and provider systems. Her published work emphasizes outcomes-driven models that benefit both patients and the broader specialty pharmacy ecosystem.

"I've dedicated my career to dismantling access barriers in specialty pharmacy," said Cherry. "Joining Loopback is an opportunity to scale those efforts—to help health systems thrive while supporting manufacturers in connecting patients to life-changing therapies."

Cherry's appointment reflects Loopback's continued commitment to empowering health system specialty pharmacies with the infrastructure and insights needed to serve as high-performing industry partners.

Life sciences organizations interested in collaborating on innovative access strategies can learn more at www.loopbackanalytics.com.

About Loopback Analytics
Loopback Analytics connects health systems and life sciences companies to expand access, strengthen performance, and improve outcomes in specialty care. For health systems, Loopback provides data-driven insights and services that empower specialty pharmacy leaders to optimize operations, unlock market access, and demonstrate clinical and economic value. For life sciences companies, Loopback delivers deep real-world data and scalable health system channel solutions that accelerate evidence generation and enable more effective patient access strategies. Together, we turn data into access, insight into action, and collaboration into progress for patients and the partners who power their care. Learn more at www.loopbackanalytics.com.

Media Contact
Bri Dendy, Marketing Specialist
[email protected]

SOURCE Loopback Analytics